We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
1,080 hedge funds and large institutions have $64B invested in Regeneron Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 367 increasing their positions, 418 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more funds holding in top 10
Funds holding in top 10: 22 → 34 (+12)
34% more first-time investments, than exits
New positions opened: 114 | Existing positions closed: 85
17% more capital invested
Capital invested by funds: $54.7B → $64B (+$9.29B)
2% more funds holding
Funds holding: 1,063 → 1,080 (+17)
0.77% more ownership
Funds ownership: 86.18% → 86.95% (+0.77%)
12% less repeat investments, than reductions
Existing positions increased: 367 | Existing positions reduced: 418
21% less call options, than puts
Call options by funds: $1.17B | Put options by funds: $1.49B
Holders
1,080
Holders Change
+17
Holders Change %
+1.6%
% of All Funds
18.61%
Holding in Top 10
34
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+54.55%
% of All Funds
0.59%
New
114
Increased
367
Reduced
418
Closed
85
Calls
$1.17B
Puts
$1.49B
Net Calls
-$320M
Net Calls Change
-$52.9M
Top Buyers
Top Sellers
| 1 |
Harris Associates
Chicago,
Illinois
|
-$248M |
| 2 |
Renaissance Technologies
New York
|
-$236M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$112M |
| 4 |
Two Sigma Advisers
New York
|
-$103M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$75.6M |